RTX Corp: Form 10-Q for the period ended Mar 31, 2014
Filed with the SEC on Apr 25, 2014 and accepted by EDGAR at Apr 25, 2014, 10:57 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-01-01 to 2014-03-31 | $14.74bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2014-01-01 to 2014-03-31 | $8.08bn | us-gaap:CostOfGoodsSold |
| Research and development | 3 months2014-01-01 to 2014-03-31 | $624.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2014-01-01 to 2014-03-31 | $1.60bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2014-01-01 to 2014-03-31 | $2.10bn | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2014-01-01 to 2014-03-31 | $567.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-01-01 to 2014-03-31 | $1.21bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-01-01 to 2014-03-31 | $1.32 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-01-01 to 2014-03-31 | $1.35 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2014-01-01 to 2014-03-31 | 917,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2014-01-01 to 2014-03-31 | $1.33bn | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months2014-01-01 to 2014-03-31 | $333.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 3 months2014-01-01 to 2014-03-31 | $514.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2014-01-01 to 2014-03-31 | $335.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2014-03-31 | $29.82bn | us-gaap:AssetsCurrent |
| Total assets | At period end2014-03-31 | $91.23bn | us-gaap:Assets |
| Current liabilities | At period end2014-03-31 | $22.93bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-03-31 | $57.40bn | us-gaap:Liabilities |
| Long-term debt | At period end2014-03-31 | $19.86bn | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2014-03-31 | $188.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2014-03-31 | $32.32bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2014-03-31 | 916,731,329 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000101829-14-000016. Last ingested by Listed: Nov 3, 2026, 21:25 ET. Listed shows no prices and gives no investment advice.